Halis Akturk, MD
Enriched profileAssociate Professor of Medicine and Pediatrics, Barbara Davis Center for Diabetes · University of Colorado Anschutz Medical Campus
Halis Akturk is Associate Professor of Medicine and Pediatrics, Barbara Davis Center for Diabetes at University of Colorado Anschutz Medical Campus. OpenAlex indexes 218 publications with 4,202 citations (h-index 35); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Halis Akturk, M.D, is Associate Professor of Medicine and Pediatrics, Barbara Davis Center for Diabetes at University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes. The public record shows 218 publications with 4,202 citations (h-index 35), centered on Diabetes Management and Research, Diabetes Management and Education, Diabetes Treatment and Management. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 17 companies.
- Most recent indexed publication: 2026 · Diabetes, obesity & metabolism
- Top research focus: Diabetes Management and Research
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 17 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 71 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 80.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Sponsor: Medtronic MiniMed, Inc.
- A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Sponsor: Zucara Therapeutics Inc.
Industry payments
Updated 16 Oct 2026
17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- F. Hoffmann-La Roche AGProgram year20258 payments$14,115openpaymentsdata.cms.gov ↗
- Dexcom, Inc.Program year20259 payments$12,284openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year202512 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
62.7%Insulin Analog40.1%Humalog Kwikpen U-10029%Humalog22%Lantus Solostar22%Tresiba Flextouch U-10013%Novolog Flexpen7%Toujeo Solostar7%Part D<11 patientsGLP-1 receptor agonist14.7%Mounjaro55%Ozempic45%Part D<11 patients+ 2 more classes in this area
Cardiovascular
24.7%Statin11.9%Atorvastatin Calcium100%Part D≥16 patientsAngiotensin receptor blocker (ARB)6.2%Losartan Potassium100%Part D<11 patients+ 2 more classes in this area
Hormonal (systemic)
12.6%l-Thyroxine12.6%Levothyroxine Sodium80%Synthroid20%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 16 Oct 2026
28 congress contributions (2015–2025) across AACE, ADA, AMCP per OpenAlex. The most recent:
- 1104-P: Analysis of Provider Feedback on the Shared Empowerment for Early Device Success (SEEDS) Pilot Study
ADA Scientific Sessions
ADA2025Co-authorPoster - 169-OR: Association between 5,766 Different CGM Ranges and A1C in Comparison to Time in 70–180 mg/dl and Time in 70–140 mg/dl Ranges
ADA Scientific Sessions
ADA2025Co-authorOral - 2053-LB: Racial/Ethnic Distribution of People with Diabetes and Diabetes Center Staff—2024 T1D Exchange Quality Improvement Collaborative (T1DX-QI) Survey Results
ADA Scientific Sessions
ADA2025Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Glycaemic Changes After Semaglutide Discontinuation in Adults With Type 1 Diabetes Using Automated Insulin Delivery: Analysis of the ADJUST-T1D Extension Study.
Diabetes, obesity & metabolism
Clinical Trial2026 - Diabetes Technology in the Primary Care Setting: An American Diabetes Association Scientific Statement.
Journal of diabetes science and technology
Article2026 - Control-IQ Technology Provides Similar Glycemic Outcomes Across Two Different Continuous Glucose Monitoring Sensors.
Journal of diabetes science and technology
Article2026 - Progression of Diabetic Retinopathy After Initiation of Automated Insulin Delivery System in Adults With Type 1 Diabetes.
Journal of diabetes science and technology
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/halis-akturk-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗
Editorial & leadership roles
journal and society appointments- Communications Director
American Diabetes Association Diabetes Technology Interest Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗ - Founder and Director
Diabetes Dialog (annual diabetes technology workshop for endocrinology fellows)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pro.aace.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Bonaca, MD
University of Colorado Anschutz Medical Campus
Satish Garg, MD
University of Colorado Anschutz Medical Campus
Jeffrey Bennett, MD
University of Colorado Anschutz Medical Campus
Jane Reusch, MD
University of Colorado Anschutz Medical Campus
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine